Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience

被引：0
|
作者：
Maren Bienert
Ingrid Reisinger
Stefanie Srock
Beatrice I Humplik
Christel Reim
Thomas Kroessin
Norbert Avril
Antonio Pezzutto
Dieter L Munz
机构：
[1] Charité—Universitätsmedizin Berlin,Clinic for Nuclear Medicine
[2] Charité—Universitätsmedizin Berlin,Department of Haematology and Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2005年 / 32卷
关键词：
Non-Hodgkin’s lymphoma; Radioimmunotherapy; I-rituximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1225 / 1233
页数：8
相关论文
共 50 条
  • [41] RITUXIMAB CLEARANCE IN PEDIATRIC PATIENTS WITH MAATURE B-CELL NON-HODGKIN LYMPHOMA
    Toelle, I.
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfing, M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    LEUKEMIA RESEARCH, 2022, 121 : S23 - S24
  • [42] Rituximab subcutaneous in B-cell non-Hodgkin lymphoma: clinical experience in a single center
    Sanchez-Gonzalez, Blanca
    Torres, Elena
    Ferraro Rosset, Mariana Paola
    Calafell, Montserrat
    Gale, Carmen
    Martinez, Laia
    Sancho, Esther
    Garcia, Pilar
    Gimeno, Eva
    Garcia-Pallarols, Francesc
    Salar, Antonio
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 1019 - 1021
  • [43] Radioimmunotherapy for B-Cell Non-Hodgkin Lymphomas
    Tomblyn, Michael
    CANCER CONTROL, 2012, 19 (03) : 196 - 203
  • [44] High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab
    Becker, W
    Behr, T
    ANNALS OF HEMATOLOGY, 2001, 80 : B130 - B131
  • [45] High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab
    W. Becker
    Th. Behr
    Annals of Hematology, 2001, 80 (Suppl 3) : B130 - B131
  • [46] A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy
    Goy, Andre
    Forero, Andres
    Wagner-Johnston, Nina
    Ehmann, W. Christopher
    Tsai, Michaela
    Hatake, Kiyohiko
    Ananthakrishnan, Revathi
    Volkert, Angela
    Vandendries, Erik
    Ogura, Michinori
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (04) : 571 - 581
  • [47] Severe hypercalcaemia as initial manifestation of B-cell non-Hodgkin's lymphoma
    Priego, M
    Roldán, V
    Herola, AG
    de Teresa, L
    MEDICINA CLINICA, 2001, 117 (02): : 76 - 77
  • [48] The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy
    Choi, Joon Ho
    Lim, Ilhan
    Byun, Byung Hyun
    Kim, Byung Il
    Choi, Chang Woon
    Kang, Hye Jin
    Shin, Dong-Yeop
    Lim, Sang Moo
    PLOS ONE, 2022, 17 (09):
  • [49] PHASE II STUDY OF FIRST-LINE I-131-RITUXIMAB RADIOIMMUNOTHERAPY OF FOLLICULAR NON-HODGKIN LYMPHOMA: THE INITIAL STUDY
    Macdonald, W.
    McQuillan, A.
    Turner, J. H.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 16 - 17
  • [50] Chemokine upregulation in response to rituximab in B-cell non-Hodgkin's lymphoma.
    Ansell, SM
    Tschumper, RC
    Witzig, TE
    Kurtin, PJ
    Jelinek, DF
    BLOOD, 1999, 94 (10) : 86A - 86A
12345